These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 21411514)

  • 21. [Congenital hyperinsulinism in newborn and infant].
    Giurgea I; Ribeiro MJ; Boddaert N; Touati G; Robert JJ; Saudubray JM; Jaubert F; Bellanné-Chantelot C; Brunelle F; Nihoul-Fékété C; de Lonlay P
    Arch Pediatr; 2005 Nov; 12(11):1628-35. PubMed ID: 16198094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genotypes of the pancreatic beta-cell K-ATP channel and clinical phenotypes of Japanese patients with persistent hyperinsulinaemic hypoglycaemia of infancy.
    Ohkubo K; Nagashima M; Naito Y; Taguchi T; Suita S; Okamoto N; Fujinaga H; Tsumura K; Kikuchi K; Ono J
    Clin Endocrinol (Oxf); 2005 Apr; 62(4):458-65. PubMed ID: 15807877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sar1-GTPase-dependent ER exit of KATP channels revealed by a mutation causing congenital hyperinsulinism.
    Taneja TK; Mankouri J; Karnik R; Kannan S; Smith AJ; Munsey T; Christesen HB; Beech DJ; Sivaprasadarao A
    Hum Mol Genet; 2009 Jul; 18(13):2400-13. PubMed ID: 19357197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutations in the genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) in diabetes mellitus and hyperinsulinism.
    Gloyn AL; Siddiqui J; Ellard S
    Hum Mutat; 2006 Mar; 27(3):220-31. PubMed ID: 16416420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro insulin secretion by pancreatic tissue from infants with diazoxide-resistant congenital hyperinsulinism deviates from model predictions.
    Henquin JC; Nenquin M; Sempoux C; Guiot Y; Bellanné-Chantelot C; Otonkoski T; de Lonlay P; Nihoul-Fékété C; Rahier J
    J Clin Invest; 2011 Oct; 121(10):3932-42. PubMed ID: 21968111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Defective trafficking and function of KATP channels caused by a sulfonylurea receptor 1 mutation associated with persistent hyperinsulinemic hypoglycemia of infancy.
    Cartier EA; Conti LR; Vandenberg CA; Shyng SL
    Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2882-7. PubMed ID: 11226335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular and immunohistochemical analyses of the focal form of congenital hyperinsulinism.
    Suchi M; MacMullen CM; Thornton PS; Adzick NS; Ganguly A; Ruchelli ED; Stanley CA
    Mod Pathol; 2006 Jan; 19(1):122-9. PubMed ID: 16357843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carbamazepine as a novel small molecule corrector of trafficking-impaired ATP-sensitive potassium channels identified in congenital hyperinsulinism.
    Chen PC; Olson EM; Zhou Q; Kryukova Y; Sampson HM; Thomas DY; Shyng SL
    J Biol Chem; 2013 Jul; 288(29):20942-20954. PubMed ID: 23744072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The spectrum of ABCC8 mutations in Norwegian patients with congenital hyperinsulinism of infancy.
    Sandal T; Laborie LB; Brusgaard K; Eide SA; Christesen HB; Søvik O; Njølstad PR; Molven A
    Clin Genet; 2009 May; 75(5):440-8. PubMed ID: 19475716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sulfonylurea receptors type 1 and 2A randomly assemble to form heteromeric KATP channels of mixed subunit composition.
    Chan KW; Wheeler A; Csanády L
    J Gen Physiol; 2008 Jan; 131(1):43-58. PubMed ID: 18079561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activating mutations in the ABCC8 gene in neonatal diabetes mellitus.
    Babenko AP; Polak M; Cavé H; Busiah K; Czernichow P; Scharfmann R; Bryan J; Aguilar-Bryan L; Vaxillaire M; Froguel P
    N Engl J Med; 2006 Aug; 355(5):456-66. PubMed ID: 16885549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dominantly acting ABCC8 mutations in patients with medically unresponsive hyperinsulinaemic hypoglycaemia.
    Flanagan SE; Kapoor RR; Banerjee I; Hall C; Smith VV; Hussain K; Ellard S
    Clin Genet; 2011 Jun; 79(6):582-7. PubMed ID: 20573158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. N-terminal transmembrane domain of SUR1 controls gating of Kir6.2 by modulating channel sensitivity to PIP2.
    Pratt EB; Tewson P; Bruederle CE; Skach WR; Shyng SL
    J Gen Physiol; 2011 Mar; 137(3):299-314. PubMed ID: 21321069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Congenital hyperinsulinism in Brazilian neonates: a study of histology, KATP channel genes, and proliferation of β cells.
    Lovisolo SM; Mendonça BB; Pinto EM; Manna TD; Saldiva PH; Zerbini MC
    Pediatr Dev Pathol; 2010; 13(5):375-84. PubMed ID: 20482375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complex ABCC8 DNA variations in congenital hyperinsulinism: lessons from functional studies.
    Muzyamba M; Farzaneh T; Behe P; Thomas A; Christesen HB; Brusgaard K; Hussain K; Tinker A
    Clin Endocrinol (Oxf); 2007 Jul; 67(1):115-24. PubMed ID: 17466004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The ATP-sensitive K(+) channel ABCC8 S1369A type 2 diabetes risk variant increases MgATPase activity.
    Fatehi M; Raja M; Carter C; Soliman D; Holt A; Light PE
    Diabetes; 2012 Jan; 61(1):241-9. PubMed ID: 22187380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A heterozygous activating mutation in the sulphonylurea receptor SUR1 (ABCC8) causes neonatal diabetes.
    Proks P; Arnold AL; Bruining J; Girard C; Flanagan SE; Larkin B; Colclough K; Hattersley AT; Ashcroft FM; Ellard S
    Hum Mol Genet; 2006 Jun; 15(11):1793-800. PubMed ID: 16613899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protein kinase C modulation of recombinant ATP-sensitive K(+) channels composed of Kir6.1 and/or Kir6.2 expressed with SUR2B.
    Thorneloe KS; Maruyama Y; Malcolm AT; Light PE; Walsh MP; Cole WC
    J Physiol; 2002 May; 541(Pt 1):65-80. PubMed ID: 12015420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperinsulinism of infancy: novel ABCC8 and KCNJ11 mutations and evidence for additional locus heterogeneity.
    Tornovsky S; Crane A; Cosgrove KE; Hussain K; Lavie J; Heyman M; Nesher Y; Kuchinski N; Ben-Shushan E; Shatz O; Nahari E; Potikha T; Zangen D; Tenenbaum-Rakover Y; de Vries L; Argente J; Gracia R; Landau H; Eliakim A; Lindley K; Dunne MJ; Aguilar-Bryan L; Glaser B
    J Clin Endocrinol Metab; 2004 Dec; 89(12):6224-34. PubMed ID: 15579781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. K(ATP) channel pharmacogenomics: from bench to bedside.
    Sattiraju S; Reyes S; Kane GC; Terzic A
    Clin Pharmacol Ther; 2008 Feb; 83(2):354-7. PubMed ID: 17957187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.